Physician

Jason P Raasch, MD

According to 2025 Medicare claims, Jason Raasch, MD (NPI: 1811095854) practices allergy/immunology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Hennepin, MN. This provider's primary affiliated billing organization is MIDWEST IMMUNOLOGY CLINICS, PLLC (NPI: 1457417933; TIN: 411961772) and primary practice location at 55446-9998. Raasch is affiliated with the Mayo Clinic Community ACO, LLC (ACO ID: A4617), participating under the MSSP model.

Raasch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 262 traditional Medicare patients, billed 104,218 HCPCS/CPT codes, and received $2,497,571 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 263 prescription claims across 54 beneficiaries totaling $1,125,968 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 257 claims. Open Payments data shows 113 records totaling $1,158,767. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $448,142 to $2,497,571. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $596,690 and ending at $1,125,968. In contrast, DME billing represents a smaller volume and rose steadily, from $1,593 to $5,717.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	79	35,229	$448,142
2016	69	41,744	$456,969
2017	79	34,376	$557,243
2018	95	32,127	$640,474
2019	157	55,797	$1,389,539
2020	132	107,580	$2,695,383
2021	173	92,879	$2,334,793
2022	217	121,326	$3,217,237
2023	243	128,452	$3,514,220
2024	262	104,218	$2,497,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	50	235	$596,690
2016	52	273	$274,617
2017	54	326	$290,416
2018	58	233	$26,811
2019	65	281	$647,145
2020	45	305	$1,288,196
2021	30	104	$159,532
2022	45	140	$196,167
2023	44	171	$1,241,911
2024	54	263	$1,125,968

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	51	$78,170
2016	N/R	12	$33,930
2017	N/R	N/R	N/R
2018	N/R	42	$992
2019	N/R	97	$102,361
2020	N/R	108	$113,567
2021	N/R	74	$105,118
2022	N/R	173	$273,935
2023	N/R	185	$320,574
2024	41	257	$469,692

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	60	91	$94
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	72	265	$44
96366	Infusion into a vein for therapy, prevention, or diagnosis, each additional hour	46	327	$15
96375	Injection of additional new drug or substance into vein	66	181	$11
96372	Injection of drug or substance under skin or into muscle	64	173	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	14	392	$717,260
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	21	588	$192,379
Cutaquig	Immun Glob G(Igg)-Hipp/Maltose	20	560	$99,889
Cuvitru	Immun Glob G(Igg)/Gly/Iga Ov50	18	504	$77,347
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	252	$31,107

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	12	54	$237,288
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	33	$222,390
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	14	$4,615
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	13	55	$4,062
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	16	85	$1,108

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	64	$48,009	Pharming Healthcare, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	48	$1,110,758	AstraZeneca UK Limited
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$8,531	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Jason P. Raasch, MD?

Tedicare shows public-source Medicare data for Jason P. Raasch, MD (NPI 1811095854), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason P. Raasch, MD have ACO affiliation data?

Jason P. Raasch, MD is shown with ACO affiliation data for Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617).

What billing organization is linked to Jason P. Raasch, MD?

Jason P. Raasch, MD is linked to MIDWEST IMMUNOLOGY CLINICS, PLLC (billing NPI 1457417933) in the available physician profile data.

Does Jason P. Raasch, MD have Open Payments data?

Jason P. Raasch, MD has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.